Markets

Market Nav

PIRAMAL PHARMA LTD.

  • NSE CodePPLPHARMAEQ
  • BSE Code543635
  • ISININE0DK501011
  • IndustryPharmaceuticals

Company Information

Management

Incorporation Year

04/03/2020

Registered Address

Registered Office : Ground Floor, Piramal Ananta, Agastya Corporate Park, Kamani Junction,LBS Marg, Kurla (West),
Mumbai, Maharashtra - 400070
Tel: 022-38023000, 38024000

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

shareholders.ppl@piramal.com

Website

http://www.piramalpharma.com

Listing

BSE, BSE, BSE, NSE, NSE

Corporate News

Piramal Pharma - Analysts/Institutional Investor Meet...

04-May-2026|3:22PM

Intimation of Schedule of Analyst/ Institutional Investor Meeting under the

Piramal Pharma - Announcement under Regulation 30 (LO...

04-May-2026|3:16PM

Intimation of Schedule of Analyst/ Institutional Investor Meeting under the

Piramal Pharma - Announcement under Regulation 30 (LO...

30-Apr-2026|2:53PM

Transcript of Conference Call on the Audited Financial Results (Standalone

Piramal Pharma - Analysts/Institutional Investor Meet...

30-Apr-2026|2:46PM

Transcript of Conference Call on the Audited Financial Results (Standalone

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug88.00249.52
Aarti Drug397.653,629.35
Aarti Pharma777.657,050.00
Abbott India26,700.0056,735.64
Accent Micro459.951,103.37

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
HDFC Fl..1228.861.35
HDFC Fo..411.821.70
Bandhan..135.130.67
Frankli..84.031.11
Canara ..83.460.72

Board Meetings

DatePurpose
28/04/2026Audited Results
28/01/2026Quarterly Results
05/11/2025Quarterly Results
28/07/2025Quarterly Results
14/05/2025Audited Results & F..